Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.39B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1B |
| 3 |
Citigroup
C
|
+$332M |
| 4 |
Apple
AAPL
|
+$307M |
| 5 |
Oracle
ORCL
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$579M |
| 2 |
EA
Electronic Arts
EA
|
+$233M |
| 3 |
Keurig Dr Pepper
KDP
|
+$215M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$206M |
| 5 |
XL
XL Group Ltd.
XL
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.09% |
| 2 | Financials | 12.89% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Acadia Realty Trust
AKR
$2.92B
| $825K | ﹤0.01% |
29,444
-22,348
| -43% | -$618K |
|
2952
Celldex Therapeutics
CLDX
$3.23B
| $824K | ﹤0.01% |
121,817
-23,380
| -16% | -$164K |
|
2953
PUT
W.W. Grainger
GWW
$61.6B
| $822K | ﹤0.01% |
+2,300
| New | +$792K |
|
2954
Minerals Technologies
MTX
$2.25B
| $822K | ﹤0.01% |
12,154
-9,265
| -43% | -$654K |
|
2955
ICICI Bank
IBN
$108B
| $821K | ﹤0.01% |
96,733
-369,077
| -79% | -$3.26M |
|
|
TBIO
2956
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $819K | ﹤0.01% |
81,863
-27,788
| -25% | -$324K |
|
2957
PUT
Kroger
KR
$35.6B
| $815K | ﹤0.01% |
+28,000
| New | +$833K |
|
2958
Gogo Inc
GOGO
$356M
| $814K | ﹤0.01% |
+156,831
| New | +$695K |
|
2959
Global X Uranium ETF
URA
$6.74B
| $810K | ﹤0.01% |
+60,876
| New | +$778K |
|
2960
Cocrystal Pharma
COCP
$22M
| $805K | ﹤0.01% |
26,821
-7,370
| -22% | -$330K |
|
2961
Quaker Houghton
KWR
$2.82B
| $801K | ﹤0.01% |
+3,960
| New | +$692K |
|
2962
Neogen
NEOG
$2.53B
| $797K | ﹤0.01% |
+22,278
| New | +$950K |
|
2963
iShares MSCI Canada ETF
EWC
$6.95B
| $796K | ﹤0.01% |
27,666
-42,334
| -60% | -$1.22M |
|
2964
Merchants Bancorp
MBIN
$2.47B
| $795K | ﹤0.01% |
46,886
-59,850
| -56% | -$1.07M |
|
2965
CALL
Booking.com
BKNG
$161B
| $794K | ﹤0.01% |
10,000
-112,500
| -92% | -$8.86M |
|
2966
PUT
Tesla
TSLA
$1.4T
| $794K | ﹤0.01% |
+45,000
| New | +$937K |
|
|
EGRX
2967
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $794K | ﹤0.01% |
+11,459
| New | +$869K |
|
2968
Wabtec
WAB
$49.8B
| $793K | ﹤0.01% |
7,560
-28,826
| -79% | -$3.11M |
|
|
XCRA
2969
DELISTED
Xcerra Corporation
XCRA
| $793K | ﹤0.01% |
55,566
+23,780
| +75% | +$337K |
|
2970
Corcept Therapeutics
CORT
$13.3B
| $790K | ﹤0.01% |
56,319
-71,585
| -56% | -$1M |
|
2971
Capital Bancorp
CBNK
$593M
| $789K | ﹤0.01% |
+62,000
| New | +$793K |
|
2972
Gentherm
THRM
$1.22B
| $789K | ﹤0.01% |
+17,363
| New | +$788K |
|
|
HYPD
2973
Hyperion DeFi Inc
HYPD
$53.1M
| $788K | ﹤0.01% |
2,451
-818
| -25% | -$364K |
|
2974
Banc of California
BANC
$2.94B
| $787K | ﹤0.01% |
41,647
-942,670
| -96% | -$18.6M |
|
2975
Forward Air
FWRD
$586M
| $785K | ﹤0.01% |
10,943
-16,368
| -60% | -$1.04M |
|
Similar funds
Israel Englander's Q3 2018 Portfolio in Review
As of Q3 2018, Israel Englander held 4,590 positions worth $81.6B, up 6.4% from $76.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander's Q3 2018 filing shows 841 new, 1,291 increased, 1,638 reduced and 748 closed positions. Its largest new stake was Fortive: 27,116,929 shares worth $1.44B. The largest sale was Altaba Inc, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- Israel Englander's largest Q3 2018 buy was Fortive: 27,116,929 shares worth $1.44B.
- Israel Englander added most to Andeavor in Q3 2018, an estimated $1B increase.
- Israel Englander's biggest Q3 2018 reduction was Altaba Inc, cutting an estimated $579M.
- Israel Englander fully exited XL Group Ltd. in Q3 2018, selling an estimated $190M.
- Israel Englander's ten largest holdings make up 10% of its $81.6B portfolio in Q3 2018.
- Israel Englander opened 841 new positions and closed 748 in Q3 2018.
- Israel Englander's portfolio value rose 6.4% quarter-over-quarter to $81.6B.
Based on Millennium Management's 13F filing for Q3 2018, filed 14 Nov 2018.